Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Lämmle

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Nature Reviews. Nephrology|April 5, 2016
Thrombotic microangiopathy: Caplacizumab accelerates resolution of acute acquired TTPBernhard Lämmle
Thrombosis and Haemostasis|September 2, 2019
Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: Pathophysiology and Differentiation from Graft versus Host DiseaseBernhard Lämmle
Hamostaseologie|August 22, 2020
Clinical Problem Solving and Using New Paths in the Laboratory: Learning from Case StudiesBernhard Lämmle
Blood|February 18, 2017
Opana ER-induced thrombotic microangiopathyBernhard Lämmle
Blood|June 15, 2023
Mechanisms of ADAMTS13 inhibition in iTTPBernhard Lämmle
Thrombosis and Haemostasis|January 7, 2021
Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in SwineBernhard Lämmle
Blood|May 2, 2024
ADAMTS13 recovery in caplacizumab-treated TTPBernhard Lämmle
Blood|February 7, 2015
VWF and complementBernhard Lämmle
Thrombosis Journal|February 12, 2026
Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)?Alexander Laemmle, Bernhard Lämmle
Thrombosis Research|March 8, 2021
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis ResearchBernhard Lämmle, Heidi Rossmann
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Nature Reviews. Nephrology|April 5, 2016
Thrombotic microangiopathy: Caplacizumab accelerates resolution of acute acquired TTPBernhard Lämmle
Thrombosis and Haemostasis|September 2, 2019
Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: Pathophysiology and Differentiation from Graft versus Host DiseaseBernhard Lämmle
Hamostaseologie|August 22, 2020
Clinical Problem Solving and Using New Paths in the Laboratory: Learning from Case StudiesBernhard Lämmle
Blood|February 18, 2017
Opana ER-induced thrombotic microangiopathyBernhard Lämmle
Blood|June 15, 2023
Mechanisms of ADAMTS13 inhibition in iTTPBernhard Lämmle
Thrombosis and Haemostasis|January 7, 2021
Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in SwineBernhard Lämmle
Blood|May 2, 2024
ADAMTS13 recovery in caplacizumab-treated TTPBernhard Lämmle
Blood|February 7, 2015
VWF and complementBernhard Lämmle
Thrombosis Journal|February 12, 2026
Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)?Alexander Laemmle, Bernhard Lämmle
Thrombosis Research|March 8, 2021
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis ResearchBernhard Lämmle, Heidi Rossmann
Pageof 15